BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cui MY, Yi X, Zhu DX, Wu J. Aberrant lipid metabolism reprogramming and immune microenvironment for gastric cancer: a literature review. Transl Cancer Res 2021;10:3829-42. [PMID: 35116681 DOI: 10.21037/tcr-21-655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Guo C, Zhang L, Zhao M, Ai Y, Liao W, Wan L, Liu Q, Li S, Zeng J, Ma X, Tang J. Targeting lipid metabolism with natural products: A novel strategy for gastrointestinal cancer therapy. Phytother Res 2023. [PMID: 36748953 DOI: 10.1002/ptr.7735] [Reference Citation Analysis]
2 Wang D, Ye Q, Gu H, Chen Z. The role of lipid metabolism in tumor immune microenvironment and potential therapeutic strategies. Front Oncol 2022;12:984560. [DOI: 10.3389/fonc.2022.984560] [Reference Citation Analysis]
3 Tokareva AO, Starodubtseva NL, Chagovets VV, Rodionov VV, Kometova VV, Chingin KS, Frankevich VE. Lipidomic Markers of Tumor Progress in Breast Cancer Patients. Biochem Moscow Suppl Ser B 2022;16:253-263. [DOI: 10.1134/s1990750822030118] [Reference Citation Analysis]
4 Tokareva A, Starodubtseva N, Chagovets V, Rodionov V, Kometova V, Chingin K, Frankevich V. Lipidomic markers of tumor progress in breast cancer patients. BIOMED KHIM 2022;68:144-152. [DOI: 10.18097/pbmc20226802144] [Cited by in F6Publishing: 1] [Reference Citation Analysis]